Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier

International Journal of Hematology

Volumn 90, Issue 5, 2009, Pages 601-604

  Fujimoto, Katsuya ^a   Endo, Tomoyuki ^a   Nishio, Mitsufumi ^a   Obara, Masato ^a   Yamaguchi, Keisuke ^a   Takeda, Yukari ^a   Goto, Hideki ^a   Kasahara, Ikumi ^a   Sato, Norihiro ^b   Koike, Takao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute hepatitis; Hepatitis B virus; Malignant lymphoma; Splenic marginal zone lymphoma

Indexed keywords

BETA 2 MICROGLOBULIN; CD20 ANTIGEN; GALLIUM; IMMUNOGLOBULIN D; IMMUNOGLOBULIN HEAVY CHAIN; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ACUTE HEPATITIS; ADULT; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CANCER REGRESSION; CASE REPORT; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; JAPANESE; LEUKOCYTOSIS; LIVER DYSFUNCTION; LYMPHOCYTE COUNT; LYMPHOMA CELL; PERIPHERAL LYMPHOCYTE; RECURRENT DISEASE; SPLEEN SCINTISCANNING; SPLENECTOMY; SPLENIC MARGINAL ZONE LYMPHOMA; SPLENOMEGALY; VIRUS CARRIER; VIRUS EXAMINATION;

ADULT; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; REMISSION, SPONTANEOUS; SPLENECTOMY; SPLENIC NEOPLASMS;

EID: 73449083364     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0426-y     Document Type: Article

References (17)

1. C Schmid N Kirkham T Diss PG Isaacson 1992 Splenic marginal zone cell lymphoma Am J Surg Pathol 16 455 466 1:STN:280:DyaK383os1Cjuw%3D%3D 1599024
2. C Thieblemont P Felman E Callet-Bauchu A Traverse-Glehen G Salles F Berger, et al. 2003 Splenic marginal-zone lymphoma: a distinct clinical and pathological entity Lancet Oncol 4 95 103 10.1016/S1470-2045(03)00981-1 1:CAS:528:DC%2BD3sXotlCntg%3D%3D 12573351 (Pubitemid 36193169)
3. X Troussard F Valensi E Duchayne R Garand P Felman M Tulliez, et al. 1996 Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC) Br J Haematol 93 731 736 10.1046/j.1365-2141.1996.d01-1711.x 1:STN:280:DyaK283ktVertQ%3D%3D 8652403
4. L Arcaini M Lazzarino N Colombo S Burcheri E Boveri M Paulli, et al. 2006 Splenic marginal zone lymphoma: a prognostic model for clinical use Blood 107 4643 4649 10.1182/blood-2005-11-4659 1:CAS:528:DC%2BD28XlvFCgsLo%3D 16493005 (Pubitemid 43882609)
5. C Thieblemont P Felman F Berger C Dumontet P Arnaud O Hequet, et al. 2002 Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients Clin Lymphoma 3 41 47 10.3816/CLM.2002.n.010 12141954
6. S Rossol G Marinos P Carucci MV Singer R Williams NV Naoumov 1997 Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B J Clin Invest 99 3025 3033 10.1172/JCI119498 1:STN:280:DyaK2szjtFSjsA%3D%3D 9185527
7. L Gergely M Aleksza L Varoczy A Ponyi S Sipka A Illes, et al. 2004 Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients Eur J Haematol 72 336 341 10.1111/j.1600-0609. 2004.00234.x 1:CAS:528:DC%2BD2cXkt1Kgu7c%3D 15059068 (Pubitemid 38520731)
8. DS Reynolds WH Boom AK Abbas 1987 Inhibition of B lymphocyte activation by interferon-gamma J Immunol 139 767 773 1:CAS:528:DyaL2sXltlagt7Y%3D 2955050
9. PP Lee D Zeng AE McCaulay YF Chen C Geiler DT Umetsu, et al. 1997 T helper 2-dominant antilymphoma immune response is associated with fatal outcome Blood 90 1611 1617 1:CAS:528:DyaK2sXltlOrtLc%3D 9269780
10. J Wajchman WJ Simmons A Klein M Koneru NM Ponzio 2002 Interleukin-12-induced cytotoxicity against syngeneic B cell lymphomas of SJL/J mice Leuk Res 26 577 590 10.1016/S0145-2126(01)00179-5 1:CAS:528: DC%2BD38XjsVSqtrY%3D 12007506 (Pubitemid 34462172)
11. S Takai H Tsurumi K Ando S Kasahara M Sawada T Yamada, et al. 2005 Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy Eur J Haematol 74 158 165 10.1111/j.1600-0609.2004.00376.x 15654908 (Pubitemid 40175321)
12. A Mele A Pulsoni E Bianco P Musto A Szklo MG Sanpaolo, et al. 2003 Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study Blood 102 996 999 10.1182/blood-2002-10-3230 1:CAS:528:DC%2BD3sXlvFCmtrY%3D 12714514 (Pubitemid 36917795)
13. K Matsuo A Kusano A Sugumar S Nakamura K Tajima NE Mueller 2004 Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies Cancer Sci 95 745 752 10.1111/j.1349-7006.2004.tb03256.x 1:CAS:528:DC%2BD2cXpvFOgu78%3D 15471561 (Pubitemid 39335095)
14. C Kelaidi F Rollot S Park M Tulliez B Christoforov Y Calmus, et al. 2004 Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas Leukemia 18 1711 1716 10.1038/sj.leu.2403443 1:CAS:528: DC%2BD2cXnvV2qsLo%3D 15284859 (Pubitemid 39386352)
15. O Hermine F Lefrere JP Bronowicki X Mariette K Jondeau V Eclache-Saudreau, et al. 2002 Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection N Engl J Med 347 89 94 10.1056/NEJMoa013376 1:CAS:528:DC%2BD38XltFGrurs%3D 12110736 (Pubitemid 34753478)
16. F Wang RH Xu B Han YX Shi HY Luo WQ Jiang, et al. 2007 High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers Cancer 109 1360 1364 10.1002/cncr.22549 17326056 (Pubitemid 46466563)
17. M Mollejo J Menarguez E Lloret A Sanchez E Campo P Algara, et al. 1995 Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases Am J Surg Pathol 19 1146 1157 1:STN:280:DyaK28%2Fgt1KntA%3D%3D 7573673